News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

67,944 Results

Type

Article (1933)
Company Profile (1)
Press Release (66010)

Section

Business (21426)
Career Advice (9)
Deals (4553)
Drug Development (8144)
FDA (1792)
Job Trends (800)
News (36923)
Policy (3560)

Tag

Date

Today (13)
Last 7 days (54)
Last 30 days (196)
Last 365 days (3680)
2024 (2070)
2023 (3821)
2022 (7021)
2021 (6379)
2020 (5876)
2019 (3866)
2018 (3013)
2017 (3562)
2016 (3172)
2015 (4031)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)

Filters

Type

Article (1933)
Company Profile (1)
Press Release (66010)

Section

Business (21426)
Career Advice (9)
Deals (4553)
Drug Development (8144)
FDA (1792)
Job Trends (800)
News (36923)
Policy (3560)

Tag

Date

Today (13)
Last 7 days (54)
Last 30 days (196)
Last 365 days (3680)
2024 (2070)
2023 (3821)
2022 (7021)
2021 (6379)
2020 (5876)
2019 (3866)
2018 (3013)
2017 (3562)
2016 (3172)
2015 (4031)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)

67,944 Results for "compugen ltd".

Sort By

Compugen to Present at Upcoming Antibody Industrial Symposium

Compugen Ltd. today announced that Pierre Ferré, Ph.D, SVP, Preclinical Development and Corporate Operations, Compugen will present a case study on clinical dose selection for TIGIT monospecific and bispecific antibodies at the Antibody Industrial Symposium taking place June 20-21, 2024, Montpellier, France.

June 17, 2024
·
2 min read
Business

Compugen Appoints David Silberman as Chief Financial Officer

Compugen Ltd. today announced the appointment of David Silberman as its new Chief Financial Officer effective August 15, 2024, taking over from Alberto Sessa who will depart Compugen on the same day.

May 15, 2024
·
3 min read
Business

Compugen Reports First Quarter 2024 Results

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the first quarter ended March 31, 2024 and provided a corporate update.

May 20, 2024
·
11 min read
Drug Development

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Compugen Ltd. today announced it is entitled to receive a milestone payment from AstraZeneca (LSE/STO/Nasdaq: AZN) triggered by the dosing of the first patient in a Phase 3 trial evaluating rilvegostomig, AstraZeneca’s PD-1/TIGIT bispecific antibody.

May 30, 2024
·
7 min read
Business

Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024

Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced that the Company will release its first quarter 2024 financial results on Monday, May 20, 2024, before the U.S. financial markets open.

May 6, 2024
·
2 min read
Compugen to Participate in Two Upcoming April 2024 Investor Conferences

Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced that management will participate in the following upcoming investor conferences in April.

April 3, 2024
·
2 min read
Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential

Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential.

May 16, 2024
·
6 min read
Business

Compugen Reports Fourth Quarter and Full Year 2023 Results

Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, reported financial results for the fourth quarter and full year 2023 and provided a corporate update.

March 5, 2024
·
12 min read
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024

Compugen Ltd. today announced that management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference, Miami Beach, Florida, on Monday, March 11, 2024 at 11:20 AM ET.

February 26, 2024
·
2 min read
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy

Compugen Ltd. announced that it has been selected to give two oral presentations at the Keystone Symposium on Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance, taking place March 17-21, 2024, in Whistler, Canada.

March 11, 2024
·
3 min read

1 of 6,795

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin